{"id":7505,"date":"2020-06-25T10:51:05","date_gmt":"2020-06-25T07:51:05","guid":{"rendered":"https:\/\/ibp.org.by\/en\/?page_id=7505"},"modified":"2023-06-09T15:14:56","modified_gmt":"2023-06-09T12:14:56","slug":"nauchnaya-deyatelnost-2","status":"publish","type":"page","link":"https:\/\/ibce.by\/en\/nauchnaya-deyatelnost-2\/","title":{"rendered":"Directions of scientific research"},"content":{"rendered":"<p><section class=\"kc-elm kc-css-161199 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-430449 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\">\n<div class=\"kc-elm kc-css-633970 kc-title-wrap \">\n\n\t<h1 class=\"kc_title\">Directions of fundamental and applied scientific research of the Institute of Biophysics and Cell Engineering of the National Academy of Sciences of Belarus<\/h1>\n<\/div>\n<\/div><\/div><\/div><\/div><\/section><section class=\"kc-elm kc-css-183785 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-342865 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-264542 kc_accordion_wrapper\">\n<div class=\"kc-elm kc-css-698987 kc_accordion_section group \"><h3 class=\"kc_accordion_header ui-accordion-header\"><span class=\"ui-accordion-header-icon ui-icon\"><\/span><a href=\"#in-the-field-of-medical-biotechnology\" data-prevent=\"scroll\"><i class=\"fa-eye-dropper\"><\/i> In the field of medical biotechnology<\/a><\/h3><div class=\"kc_accordion_content ui-accordion-content kc_clearfix\"><div class=\"kc-panel-body\"><div class=\"kc-elm kc-css-159644 kc_text_block\"><\/p>\n<p>1. Genetic engineering<br \/>development of innovative biomedical cellular products based on genetically modified cells<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-100195 kc_text_block\"><\/p>\n<p>2. Immunology and allergology<br \/>development of new methods of treatment and diagnosis of allergic diseases and immune dysfunctions<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-427560 kc_text_block\"><\/p>\n<p>3. Innovative vaccines<br \/>development of prototypes of national DNA and RNA vaccines for the prevention of viral diseases<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-694785 kc_text_block\"><\/p>\n<p>4. New approaches to diagnostics<br \/>development of new technologies for early diagnosis of diseases and methods of personalized medicine aimed at improving the quality of human life<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-571030 kc_text_block\"><\/p>\n<p>5. Genome editing<br \/>somatic, induced pluripotent stem cells, which will allow to treat diseases, including orphan, genetic<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-49243 kc_text_block\"><\/p>\n<p>6. Synthetic morphogenesis<br \/>including tissue and organ engineering<\/p>\n<p>\n<\/div><\/div><\/div><\/div><div class=\"kc-elm kc-css-197967 kc_accordion_section group \"><h3 class=\"kc_accordion_header ui-accordion-header\"><span class=\"ui-accordion-header-icon ui-icon\"><\/span><a href=\"#in-the-field-of-bioinformatics-technologies\" data-prevent=\"scroll\"><i class=\"fa-laptop\"><\/i> In the field of bioinformatics technologies<\/a><\/h3><div class=\"kc_accordion_content ui-accordion-content kc_clearfix\"><div class=\"kc-panel-body\"><div class=\"kc-elm kc-css-321833 kc_text_block\"><\/p>\n<p>1. Structure-based design of new generation drugs, development of innovative targeted antitumor and antiviral drugs using structural bioinformatics methods<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-951347 kc_text_block\"><\/p>\n<p>2. Synthesis of targeted drugs and their testing under in vitro conditions<\/p>\n<p>\n<\/div><\/div><\/div><\/div><div class=\"kc-elm kc-css-398331 kc_accordion_section group \"><h3 class=\"kc_accordion_header ui-accordion-header\"><span class=\"ui-accordion-header-icon ui-icon\"><\/span><a href=\"#in-the-field-of-nanotheranostics-and-personalized-nanomedicine\" data-prevent=\"scroll\"><i class=\"fa-thermometer\"><\/i> In the field of nanotheranostics and personalized nanomedicine<\/a><\/h3><div class=\"kc_accordion_content ui-accordion-content kc_clearfix\"><div class=\"kc-panel-body\"><div class=\"kc-elm kc-css-371436 kc_text_block\"><\/p>\n<p><span style=\"color: #444444; font-family: -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Oxygen-Sans, Ubuntu, Cantarell, Helvetica Neue, sans-serif;\"><span style=\"font-size: 14px;\">1. Development of means of targeted delivery of therapeutic drugs of a new generation using nanomaterials<\/span><\/span><\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-628205 kc_text_block\"><\/p>\n<p>2. Development of biological nanochips for diagnosis of diseases.<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-351201 kc_text_block\"><\/p>\n<p>3. Research of biocompatible nanomaterials of a wide range of action for the creation of biomedical cellular products, artificial organs, fundamentally new materials with antimicrobial, antiviral and anti-inflammatory activity.<\/p>\n<p>\n<\/div><\/div><\/div><\/div><div class=\"kc-elm kc-css-677215 kc_accordion_section group \"><h3 class=\"kc_accordion_header ui-accordion-header\"><span class=\"ui-accordion-header-icon ui-icon\"><\/span><a href=\"#activities-of-the-center-for-experimental-and-applied-virology\" data-prevent=\"scroll\"><i class=\"fa-certificate\"><\/i> Activities of the Center for Experimental and Applied Virology<\/a><\/h3><div class=\"kc_accordion_content ui-accordion-content kc_clearfix\"><div class=\"kc-panel-body\"><div class=\"kc-elm kc-css-45149 kc_text_block\"><\/p>\n<p>1. Cultivation of viruses<br \/>development of new methods of cultivation of human viruses for the creation of means of diagnostics, medical prevention and treatment of viral diseases<\/p>\n<p>\n<\/div><div class=\"kc-elm kc-css-205837 kc_text_block\"><\/p>\n<p>2. Creation of vaccine prototypes<br \/>against influenza (inactivated and recombinant)<br \/>against African swine fever (vector)<br \/>against pulmonary tuberculosis (therapeutic based on donor dendritic cells)<br \/>innovative drugs against influenza<\/p>\n<p>\n<\/div><\/div><\/div><\/div><\/div>\n<\/div><\/div><\/div><\/div><\/section><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-7505","page","type-page","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/pages\/7505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/comments?post=7505"}],"version-history":[{"count":5,"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/pages\/7505\/revisions"}],"predecessor-version":[{"id":8310,"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/pages\/7505\/revisions\/8310"}],"wp:attachment":[{"href":"https:\/\/ibce.by\/en\/wp-json\/wp\/v2\/media?parent=7505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}